164 related articles for article (PubMed ID: 6967937)
21. Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell.
McMichael AJ; Askonas BA
Eur J Immunol; 1978 Oct; 8(10):705-11. PubMed ID: 309394
[TBL] [Abstract][Full Text] [Related]
22. HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2.
McMichael A
J Exp Med; 1978 Dec; 148(6):1458-67. PubMed ID: 309917
[TBL] [Abstract][Full Text] [Related]
23. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
Plotnicky H; Touraine JL
Clin Exp Immunol; 1993 Dec; 94(3):494-9. PubMed ID: 7504600
[TBL] [Abstract][Full Text] [Related]
24. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
Sumitran-Karuppan S; Möller E
Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
[TBL] [Abstract][Full Text] [Related]
25. HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines.
Ennis FA; Rook AH; Qi YH; Schild GC; Riley D; Pratt R; Potter CW
Lancet; 1981 Oct; 2(8252):887-91. PubMed ID: 6117682
[TBL] [Abstract][Full Text] [Related]
26. Regulation of influenza virus-specific cytotoxic T cell responses by monoclonal antibody to a human T cell differentiation antigen.
Biddison WE; Shearer GM; Chang TW
J Immunol; 1981 Dec; 127(6):2236-40. PubMed ID: 6457869
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte cytotoxicity to influenza virus-infected cells. II. Requirement for antibody and non-T lymphocytes.
Greenberg SB; Criswell BS; Six HR; Couch RB
J Immunol; 1977 Dec; 119(6):2100-6. PubMed ID: 334984
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic T cells specific for influenza virus-infected target cells.
Yap KL; Ada GL
Immunology; 1977 Feb; 32(2):151-9. PubMed ID: 300355
[TBL] [Abstract][Full Text] [Related]
29. H-2 and viral haemagglutinin expression by influenza-infected cells; the proteins are close but do not cocap.
Hackett CJ; Askonas BA
Immunology; 1982 Mar; 45(3):431-8. PubMed ID: 6977485
[TBL] [Abstract][Full Text] [Related]
30. Specific inhibition of T-cell-mediated cytolosis by alloantiserum against HLA-D-related (DR) antigens.
Feighery CF; Stastny P
Transplant Proc; 1979 Mar; 11(1):708-11. PubMed ID: 88098
[TBL] [Abstract][Full Text] [Related]
31. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
Galocha B; López D; López de Castro JA
J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
[TBL] [Abstract][Full Text] [Related]
32. Anti-influenza human T killer cells present an intertypic activity anti-A and -B type viruses in a secondary reaction in vitro.
Sitbon M; Gomard E; Hannoun C; Levy JP
Clin Exp Immunol; 1983 Oct; 54(1):49-58. PubMed ID: 6604611
[TBL] [Abstract][Full Text] [Related]
33. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants.
Brodsky FM; Parham P
J Immunol; 1982 Jan; 128(1):129-35. PubMed ID: 6172474
[TBL] [Abstract][Full Text] [Related]
34. Major histocompatibility complex-restricted H-Y-specific antibodies and cytotoxic T lymphocytes may recognize different self determinants.
Goulmy E; van Leeuwen A; Blokland E; van Rood JJ; Biddison WE
J Exp Med; 1982 May; 155(5):1567-72. PubMed ID: 6175722
[TBL] [Abstract][Full Text] [Related]
35. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
Gaston JS; Rickinson AB; Epstein MA
J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
[TBL] [Abstract][Full Text] [Related]
37. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
38. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
Eura M; Chikamatsu K; Katsura F; Obata A; Sobao Y; Takiguchi M; Song Y; Appella E; Whiteside TL; DeLeo AB
Clin Cancer Res; 2000 Mar; 6(3):979-86. PubMed ID: 10741724
[TBL] [Abstract][Full Text] [Related]
39. HLA molecule--cytoskeleton associations induced by cross-linking with specific antibodies.
Hasková V; Ivasková E; Macurová H
Folia Biol (Praha); 1988; 34(6):372-9. PubMed ID: 3073966
[TBL] [Abstract][Full Text] [Related]
40. Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules.
Biddison WE; Krangel MS; Strominger JL; Ward FE; Shearer GM; Shaw S
Hum Immunol; 1980 Oct; 1(3):225-32. PubMed ID: 6167549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
